Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Conservative Stock Portfolio: 5 Best Stocks to Buy Right Now

In this article, we are going to look at the Conservative Stock Portfolio: 5 Best Stocks to Buy Right Now. For a longer list and more details on how we picked these stocks, you can go to Conservative Stock Portfolio: 7 Best Stocks to Buy Right Now

5. NRG Energy, Inc. (NYSE:NRG)

NRG Energy, Inc. (NYSE:NRG) is one of the Best Conservative Stocks to Buy Right Now. On March 23, Morgan Stanley lifted its price objective on the company’s stock to $157 from $153, while keeping an “Equal Weight” rating, as reported by The Fly. The analyst highlighted that the firm has been updating its price objectives for the broader Regulated & Diversified Utilities / IPPs in North America that form part of its coverage.

In February, the utilities sector outperformed the returns delivered by S&P. Additionally, the firm opines that the recent discussions are, more or less, constructive. The companies in this space are highlighting growth opportunities and optimism on load growth, while deal-signings with data centers continue.

In a different release, Wolfe Research analyst Steve Fleishman upgraded NRG Energy, Inc. (NYSE:NRG)’s stock to “Outperform” from “Peer Perform” with a price objective of $190.

The analyst believes that NRG Energy, Inc. (NYSE:NRG)’s LS Power and Rockland Capital asset acquisitions support it in bringing back to the traditional long power generator that possesses upside sensitivity to the tightening of supply and demand.

4. Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now. On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, Abbott Laboratories (NYSE:ABT) is now a leader in fast-growing cancer screening as well as the diagnostics segment.

This acquisition places Abbott Laboratories (NYSE:ABT) well to advance diagnostics, which are more preventative, predictive, and personalized. Apart from this, it added a new growth vertical to Abbott Laboratories (NYSE:ABT)’s already high-single-digit growth outlook, which will help establish leadership in the expanding $60 billion US market focused on cancer screening and precision oncology diagnostics.

Abbott Laboratories (NYSE:ABT)’s global scale, history of achieving operational and commercial excellence, and its work with healthcare systems should help in expanding accessibility to tools for early cancer detection and personalized treatments. After the completion of the acquisition, Exact Sciences is now a wholly-owned subsidiary of Abbott Laboratories (NYSE:ABT).

Abbott Laboratories (NYSE:ABT) is a global healthcare company that manufactures a range of branded generic medications, medical devices, diagnostics, and nutritional items.

3. NextEra Energy, Inc. (NYSE:NEE)

NextEra Energy, Inc. (NYSE:NEE) is one of the Best Conservative Stocks to Buy Right Now. On March 20, the company stated that President Trump gave approval for developing up to 10 gigawatts of natural gas‑powered generation in Texas and Pennsylvania. This was done with respect to Japan’s $550 billion commitment to invest in the US, which was part of the trade deal between the US and Japan. Thanks to this, NextEra Energy, Inc. (NYSE:NEE) can now work on the development of reliable, large-scale power infrastructure. This can help in America’s growth and technological leadership.

That being said, the investment remains subject to negotiation and execution of definitive documents by NextEra Energy, Inc. (NYSE:NEE) and several constituents, and its completion of development, construction, and commissioning of certain projects. The projects will be co-owned by Japan and the U.S. as per the joint trade agreement, and will be built and operated by the company.

NextEra Energy, Inc. (NYSE:NEE) offers renewable energy.

2. Constellation Energy Corporation (NASDAQ:CEG)

Constellation Energy Corporation (NASDAQ:CEG) is one of the Best Conservative Stocks to Buy Right Now. On March 18, the company and LS Power Equity Advisors, LLC announced an agreement, according to which the former would sell a portfolio of generation assets in PJM to LS Power. This move focuses on addressing the regulatory commitments associated with Constellation Energy Corporation (NASDAQ:CEG)’s acquisition of Calpine.

The transaction demonstrates the majority of the divestitures needed by the US DOJ with regard to the antitrust review of the Calpine deal, which includes all the assets needed to be divested by FERC (Federal Energy Regulatory Commission). Talking about the agreement, LS Power plans to acquire ~4.4 gigawatts of predominantly natural gas–fired generation capacity throughout Delaware and Pennsylvania, which includes the Bethlehem, York 1, York 2, Hay Road, and Edge Moor Facilities.

Notably, the value of the transaction comes out to be $5 billion before closing adjustments. This reflects an acquisition price of ~$1,142/kW. Notably, in January 2026, Constellation Energy Corporation (NASDAQ:CEG) wrapped up the acquisition of Calpine, which led to the significant expansion of its competitive generation footprint.

Constellation Energy Corporation (NASDAQ:CEG) is engaged in generating, supplying, and marketing clean electricity and renewable energy products and solutions.

1. Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Conservative Stocks to Buy Right Now. On March 24, the company announced that it had completed the acquisition of Clario Holdings, Inc. The consideration included $8.875 billion in cash, along with potential additional earnout as well as other payments. These are mainly dependent on performance. The Clario business is now set to be a part of Thermo Fisher Scientific Inc. (NYSE:TMO)’s Laboratory Products and Biopharma Services segment.

The financial profile of Clario remains attractive, while the synergy realization makes returns compelling with a double-digit IRR. Notably, the company’s business is expected to see growth in the high single digits and can contribute $0.45 of adjusted EPS in the first year post-close. The business is also accretive to the adjusted operating margin of Thermo Fisher Scientific Inc. (NYSE:TMO).

Thermo Fisher Scientific Inc. (NYSE:TMO) anticipates realizing ~$175 million of adjusted operating income from synergies by year 5 after the close. This is expected mainly from revenue synergies, which will come from combined capabilities.

Thermo Fisher Scientific Inc. (NYSE:TMO) offers more than 2 million products and services for pharmaceutical development, biotechnology research, clinical diagnostics, as well as laboratory management.

While we acknowledge the potential of TMO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TMO and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.